However, the limited number of HCV-related HCC cases analyzed, restrains the conclusion that TERT promoter mutations might be significantly associated with WNT pathway gene alterations, such as CTNNB1 in HCV-related HCC and non-viral HCCs [6, 8]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.